Deep Health AI India Reports Strong Profit Growth Amid Acquisition Setback

Deep Health AI India posted a 51.05% increase in net profit to ₹1.30 crore for the financial year ended March 31, 2026. This was achieved on a standalone basis, with revenue from operations surging by 237.54% to ₹4.25 crore.

Reader Takeaway: Revenue and profit grew strongly; failed acquisition and fund diversion pose risks.

What just happened

Deep Health AI India Limited announced its audited standalone and consolidated financial results for the fiscal year ended March 31, 2026. The company reported a standalone net profit of ₹1.30 crore, up from ₹0.86 crore in the previous year. Revenue from operations jumped to ₹4.25 crore from ₹1.26 crore.

However, the results were marked by an exceptional loss. This loss stemmed from the failed acquisition of Oasis Ceramics Pvt. Ltd. under the Insolvency and Bankruptcy Code (IBC). The company failed to meet payment deadlines for the ₹32 crore acquisition, leading to the invocation of its ₹3.21 crore Earnest Money Deposit and bank guarantee.

Furthermore, the company's utilization of funds from its ₹39.97 crore rights issue showed a significant deviation. Only ₹2.5 crore was used for the stated acquisition purpose, while the remaining ₹37.47 crore was diverted to investments in securities via the stock exchange. This diversion was later ratified by shareholders.

Why this matters

The strong revenue and profit growth indicate operational improvement. However, the failed acquisition and the significant diversion of rights issue funds raise concerns about strategic execution and capital allocation. Investors will need to assess the implications of these events on the company's future business prospects and governance.

The backstory

Deep Health AI India had planned to acquire Oasis Ceramics Pvt. Ltd. as a key objective for its rights issue proceeds. The company also appointed M/s. Valawat & Associates as its internal auditor for FY 2026-27.

What changes now

Investors will be closely watching the company's progress with its application to the NCLT for an extension and the final decision by the Committee of Creditors regarding Oasis Ceramics. The company's strategy of investing rights issue funds in securities will also be a key area to monitor.

Risks to watch

The primary risks include potential financial losses from the failed acquisition and the implications of diverting a substantial portion of rights issue funds away from intended business objectives. The company faces execution risks related to its new investment strategy.

Peer comparison

[No peer comparison data available in the filing.]

Context metrics (time-bound)

Standalone Revenue from operations: ₹4.25 crore (FY26) vs ₹1.26 crore (FY25)
Standalone Profit Before Tax: ₹1.76 crore (FY26) vs ₹1.10 crore (FY25)
Standalone Net Profit: ₹1.30 crore (FY26) vs ₹0.86 crore (FY25)
Rights Issue Raised: ₹39.97 crore
Exceptional Loss (EMD + Bank Guarantee): ₹3.21 crore

What to track next

Investors should monitor the outcome of the NCLT application and the Committee of Creditors' decision on Oasis Ceramics. The performance of the company's investments in securities and its future capital allocation strategy will also be crucial.